Pediatrics Department, Faculty of Medicine, "Ovidius" University, 900470 Constanta, Romania.
Pediatrics Department, County Clinical Emergency Hospital of Constanta, 900591 Constanta, Romania.
Nutrients. 2023 Aug 20;15(16):3647. doi: 10.3390/nu15163647.
The first 1000 days after birth represent a critical window for gut microbiome development, which is essential for immune system maturation and overall health. The gut microbiome undergoes major changes during this period due to shifts in diet and environment. Disruptions to the microbiota early in life can have lasting health effects, including increased risks of inflammatory disorders, autoimmune diseases, neurological disorders, and obesity. Maternal and environmental factors during pregnancy and infancy shape the infant gut microbiota. In this article, we will review how maintaining a healthy gut microbiome in pregnancy and infancy is important for long-term infant health. Furthermore, we briefly include fungal colonization and its effects on the host immune function, which are discussed as part of gut microbiome ecosystem. Additionally, we will describe how potential approaches such as hydrogels enriched with prebiotics and probiotics, gut microbiota transplantation (GMT) during pregnancy, age-specific microbial ecosystem therapeutics, and CRISPR therapies targeting the gut microbiota hold potential for advancing research and development. Nevertheless, thorough evaluation of their safety, effectiveness, and lasting impacts is crucial prior to their application in clinical approach. The article emphasizes the need for continued research to optimize gut microbiota and immune system development through targeted early-life interventions.
生命最初的 1000 天是肠道微生物组发展的关键时期,这对于免疫系统成熟和整体健康至关重要。在此期间,由于饮食和环境的变化,肠道微生物组会发生重大变化。生命早期微生物组的失调会对健康产生持久的影响,包括增加炎症性疾病、自身免疫性疾病、神经退行性疾病和肥胖的风险。妊娠和婴儿期的母体和环境因素塑造了婴儿的肠道微生物组。在本文中,我们将回顾在妊娠和婴儿期维持健康的肠道微生物组对婴儿长期健康的重要性。此外,我们还简要介绍了真菌定植及其对宿主免疫功能的影响,这些内容被视为肠道微生物组生态系统的一部分进行讨论。此外,我们将描述一些潜在的方法,如富含益生元和益生菌的水凝胶、妊娠期间的肠道微生物组移植(GMT)、针对特定年龄的微生物生态疗法以及针对肠道微生物组的 CRISPR 疗法,这些方法有可能推进研究和开发。然而,在将其应用于临床方法之前,必须对其安全性、有效性和持久影响进行彻底评估。本文强调需要通过有针对性的早期干预措施继续研究,以优化肠道微生物组和免疫系统的发育。